Morgan Stanley
ORGS

Morgan Stanley’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Morgan Stanley’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$38 – 8015
2023
Q4 		$38 Sell
8
-625
-99% -$4K ﹤0.01% 7708
2023
Q3 		$3.92K Hold
633
– – ﹤0.01% 6971
2023
Q2 		$8.8K Hold
633
– – ﹤0.01% 6856
2023
Q1 		$7.47K Sell
633
-15
-2% -$282 ﹤0.01% 6965
2022
Q4 		$12.6K Sell
648
-28
-4% -$477 ﹤0.01% 6854
2022
Q3 		$9K Sell
676
-13
-2% -$244 ﹤0.01% 7126
2022
Q2 		$16K Sell
689
-55
-7% -$1.53K ﹤0.01% 7081
2022
Q1 		$26K Sell
744
-2
-0.3% -$61 ﹤0.01% 7029
2021
Q4 		$21K Hold
746
– – ﹤0.01% 7207
2021
Q3 		$36K Sell
746
-67
-8% -$3.36K ﹤0.01% 6862
2021
Q2 		$41K Buy
813
+775
+2,039% +$39K ﹤0.01% 6753
2021
Q1 		$2K Sell
38
-1,387
-97% -$90.4K ﹤0.01% 7293
2020
Q4 		$64K Buy
1,425
+1,252
+724% +$60.3K ﹤0.01% 6077
2020
Q3 		$9K Sell
173
-386
-69% -$20.9K ﹤0.01% 6312
2020
Q2 		$34K Buy
+559
New +$33.8K ﹤0.01% 5825
2018
Q4 		– Sell
-13
Closed -$1K – 6769
2018
Q3 		$1K Sell
13
-1,000
-99% -$67.7K ﹤0.01% 6662
2018
Q2 		$88K Hold
1,013
– – ﹤0.01% 5770
2018
Q1 		$104K Buy
+1,013
New +$120K ﹤0.01% 5698

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Morgan Stanley's ORGS Position: Q1 2024 in Review

Morgan Stanley sold out of Orgenesis Inc. Common Stock (ORGS) in Q1 2024, closing a stake of 8 shares — an estimated $38 sold.

Morgan Stanley first reported a position in ORGS in Q1 2018 and held it in 18 quarters. The position peaked at $104K in Q1 2018. 16 funds tracked by Wall St. Rank hold ORGS as of Q1 2024.

  • Morgan Stanley reported no remaining Orgenesis Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 8 Orgenesis Inc. Common Stock shares in Q1 2024, an estimated $38.
  • Morgan Stanley first reported a position in Orgenesis Inc. Common Stock in Q1 2018 and held it in 18 quarters.
  • Morgan Stanley's Orgenesis Inc. Common Stock position peaked at $104K in Q1 2018.
  • 16 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.